Vicplas International (SGX:569) 3-Year EPS without NRI Growth Rate : 4.60% (As of Jan. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Vicplas International 3-Year EPS without NRI Growth Rate?

Vicplas International's EPS without NRI for the six months ended in Jan. 2024 was S$0.00.

During the past 12 months, Vicplas International's average EPS without NRI Growth Rate was -75.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was 4.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Vicplas International was 39.50% per year. The lowest was -16.40% per year. And the median was -1.05% per year.

Competitive Comparison of Vicplas International's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Vicplas International's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vicplas International's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Vicplas International's 3-Year EPS without NRI Growth Rate falls into.

Vicplas International 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Vicplas International (SGX:569) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Vicplas International 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Vicplas International's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicplas International (SGX:569) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

35 Joo Koon Circle, Singapore, SGP, 629110

Website

https://www.vicplas.com

Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines